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Abstract – Equine piroplasmoses are enzootic parasitic diseases distributed worldwide with high incidence in trop-
ical and subtropical regions. In Spain, there is insufficient epidemiological data about equine piroplasmoses. The main
aim of the present study was therefore to estimate the prevalence of Theileria equi and Babesia caballi in five regions
and obtain information about the risk factors. This study was conducted in the central and south-western regions of
Spain, using indirect fluorescence antibody testing (IFAT) in 3,100 sera samples from apparently healthy horses of
different ages, breeds, coat colours, genders and geographical locations. The overall seroprevalence was 52%, con-
sisting of 44% seropositive for T. equi and 21% for B. caballi. There was a significant association between age
(p < 0.0001), breed (p < 0.004), geographical location (p < 0.0001) and the seroprevalence, but neither the coat
colour nor the gender was significantly associated with prevalence. In addition, it was proved that most of the
geographic areas showed a moderate to high prevalence. The statistical j value was used to compare the results
obtained by the IFAT and the competitive enzyme-linked immunosorbent assay (cELISA) utilised to test some sam-
ples (n = 108) and showed a higher concordance for T. equi (j = 0.68) than for B. caballi (j = 0.22). Consequently,
this revealed the importance of developing an appropriate technique to detect each haemoparasite.
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Résumé – Séroprévalence de Theileria equi et Babesia caballi chez les chevaux en Espagne. Les piroplasmoses
équines sont des parasitoses enzootiques cosmopolites qui existent surtout dans les régions tropicales et subtropicales.
En Espagne, peu de données épidémiologiques sont disponibles sur les piroplasmoses équines. Ainsi, le principal
objectif de la présente étude a été d’estimer la séroprévalence de l’infection par Theileria equi et Babesia caballi
dans cinq régions et obtenir des informations sur les facteurs de risque. Cette étude a été menée dans les régions
du centre et du sud-ouest de l’Espagne en utilisant le test d’immunofluorescence indirecte (IFI) sur un échantillon
de 3100 sérums de chevaux apparemment sains de différents âges, races, robes, sexe et origines géographiques.
La séroprévalence globale était de 52 %, y compris 44 % séropositifs pour T. equi et 21 % pour B. caballi. Il y
avait une association significative entre l’âge (p < 0.0001), la race (p < 0.004), la localisation géographique
(p < 0.0001) et la séroprévalence. Cependant, ni la couleur du pelage ni le sexe n’avaient de corrélation
significative avec la séroprévalence. En outre, la plupart des régions étaient dans un état de prévalence modérée à
élevée. Le coefficient de concordance j a été utilisé pour comparer les résultats obtenus par IFI et cELISA pour
tester 108 échantillons, et a montré une concordance plus élevée pour T. equi (j = 0.68) que pour B. caballi
(j = 0.22). Cela démontre l’importance de développer une technique appropriée pour détecter chaque hémoparasite.
Introduction
Equine piroplasmoses (EPs) are important and widespread
tick-borne diseases in horses. This parasitic disease affects all
equid species including horses, donkeys, mules and zebras.
Two species of parasites, Babesia caballi (Nuttall and
Strickland 1910) and Theileria equi (formerly Babesia equi,
Laveran 1901), cause this infection. These protozoa parasitise
erythrocytes and they can co-infect animals [18, 65, 83].
The disease is characterised by a variety of symptoms such
as fever, anaemia, jaundice, haematuria and lymphadenopathy
[32]. The initial acute phase can cause death, but the survivor
animals become carriers and reservoirs of infection for vector
ticks [28]. Therefore, large economic losses are generated due*Corresponding author: pepelufe@unex.es
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to the treatments, the decrease in performance of the animals
or the negative impact on international trade [31, 56].
In Spain, EPs are enzootic diseases [13, 31] as they have
been diagnosed in autochthonous horses for decades [21, 22,
41–43] but there is insufficient epidemiological information
about this disease and its vectors in Spain.
Several diagnostic methods are used to detect the infection,
such as microscopic examination of stained blood smears,
which is useful in the acute phase of infection onset, though
serological techniques are better in order to identify chronic
carriers. These techniques include the complement fixation test
(CFT), the indirect fluorescent antibody test (IFAT), and the
competitive enzyme-linked immunosorbent assay (cELISA),
which utilises the EMA-1 protein and a specific monoclonal
antibody (MAb) to detect T. equi, and the recombinant RAP-1
protein and an MAb reactive with a peptide epitope of a 60
KDa B. caballi antigen to diagnose the other parasite. The last
two tests are recommended by the World Organisation for
Animal Health (OIE) for the serodiagnosis of EP [73]. The diag-
nosis of these haemoprotozoan infections can be carried out
using molecular assays such as conventional single PCR [13],
multiplex PCR [7, 96], nested PCR [72, 78, 95] or real-time
PCR [54]. Thus, the combination of two or more of these
methods is currently recommended to diagnose the EP [102].
The main goal of this survey was to estimate the seropreva-
lence and geographic distribution of EP in central and south-
west Spain. In fact, it is the largest study that has been
conducted in Spain. It is intended to identify areas in which
to implement more effective control measures against both
the pathogens and their vectors. In addition, we analysed 108
randomly selected sera samples to compare concordance of
the two serological methods most often used in the diagnosis
of this parasitic infection that affects equids in Spain: the indi-
rect fluorescence antibody test (IFAT) vs. an immunoenzymatic
assay (cELISA). This study helped to further understand the
situation of the Purebred Spanish Horse with regard to these
infections in this emblematic and autochthonous breed.
Materials and methods
Sampled animals and area of study
This study was carried out between February and
September 2014 in various regions of Spain: Andalusia,
Castilla-La Mancha, Castilla-León, Extremadura and Madrid
(Fig. 1). Blood samples were collected from horses’ jugular
veins into sterile vacuum tubes with and without anticoagulant.
Plasma and serum samples were obtained by centrifugation at
4 C at 2500 rpm for 10 min and were stored at 20 C until
testing. The plasma and sera were used for the IFAT and the
cELISA, respectively.
This study included 3100 animals (1309 females and 1791
males) with no clinical signs of piroplasmoses between
9 months and 30 years of age (mean age: 7.5 years). Different
breeds were tested including the Spanish Pure Breed horse,
Anglo-Arabian, Arabian horse, Balearic horse, Hanoverian
horse, Lusitano, Thoroughbred, Selle Français and crossbred
horses. Information on aptitude was annotated; thus, most of
the animals were breeding horses though there were saddle
horses (recreation or sports). Data were studied according to
recorded information sent by owners and/or veterinarians:
gender, breed, age, geographical origin and coat colour.
Win Episcope 2.0 was used [99] to estimate the minimal
sample size needed to guarantee the validity of this study.
According to the equine census data obtained in 2013 from
MAGRAMA (‘‘Ministerio de Agricultura, Alimentación y
Medio Ambiente’’, Spain) [61] in each region studied
(Table S1), at least 381 animals from each area were sufficient
in order to detect a 50% prevalence of subclinical EP infection
with a certainty of 95% [89]. However, in the region of Madrid,
the sample size was smaller than necessary (n = 312) (Fig. 1,
Table S1).
Indirect fluorescence antibody test (IFAT) and
immunoenzymatic assay (cELISA)
The IFAT was used for the detection of antibodies against
T. equi and B. caballi. The antigen was obtained from naturally
infected horses with a parasitaemia higher than 3%. Both pro-
tocols to prepare the T. equi and the B. caballi antigen and the
assay were conducted as described by Camacho et al. [21]. The
slides were examined under the fluorescence microscope
(Leica DMLS) at a magnification of 400 (10 · 40). Positive
and negative sera were included in each run as controls.
The cELISA test was carried out with commercially
available test kits (VMRD, Inc. Pullman, WA, USA) to detect
antibodies against T. equi and B. caballi. These tests were
conducted following the manufacturer’s instructions. The
plates were read on a plate reader (Multiskan Ascent, Thermo
Electron Corporation) at an optical density of 620 nm.
Samples associated with percent inhibition (PI) values <40%
were considered negative, while if the PI value was40%, sera
were considered positive.
The IFAT and the cELISA techniques are the most useful
methods to diagnose equine piroplasmoses. For this reason, a
comparison between the techniques was needed since it had
not been done previously in Spain. Thus, from the 3100 serum
samples tested by IFAT, 108 samples were randomly selected
and tested by cELISA.
Statistical analysis
The seroprevalences of T. equi, B. caballi and co-infection
relative to certain characteristics (age, breed, coat colour,
gender and geographical location) were determined at the
95% confidence interval (CI). These epidemiological data were
compared with the IFAT results using a logistic regression-
binary (LR-binary). Animals were considered as units of analy-
sis for determining the significance of association. Data analyses
were performed using Statistical Package for Social Sciences
(SPSS) 11.0 software for Windows. The odds ratios were
calculated at a 95% confidence interval (95% CI). Tests with a
p-value  0.05 were considered statistically significant.
Due to the semi-quantitative characteristic of age as a vari-
able, it was evaluated by both (i) exploring the difference in
means between categories in the IFAT variable, and (ii) using
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it as an ordinal variable, then using the OR calculated as the
average value of each risk factor compared to the previous in
descending order. The statistical significance of seroprevalence
between pairs of regions (Castilla-La Mancha, Andalusia,
Castilla-León, Extremadura and Madrid) was calculated using
a non-parametric test with the Monte Carlo Method. In order to
determine the concordance between the two serological
techniques (the IFAT and the cELISA), Cohen’s j test was used
[24]. The j values < 0 indicate no agreement and values
between 0 and 0.20 indicate slight agreement, 0.21–0.4 fair
agreement, 0.41–0.60 moderate, 0.61–0.80 substantial and
0.81–1 almost perfect agreement.
Results
Seroepidemiological study
The serological examination of 3100 horses by IFAT
showed that the overall seroprevalence of the equine piroplas-
moses in southwest Spain was 52.45% (SE = 0.009). Of the
3100 tested samples, 1381 sera (44.55%; SE = 0.009) were
positive for T. equi, 643 samples (20.74%; SE = 0.007) were
positive for B. caballi and 398 horses (12.84%; SE = 0.006)
had antibodies against both parasites.
The seroprevalence in horses from Castilla-La Mancha was
the highest (67.54%) (significance calculated by the Monte
Carlo method [95% CI]; p < 0.001). The prevalence results
in horses from Andalusia, Castilla-León and Extremadura
(50.94%; 53.62% and 51.5%, respectively) were not statisti-
cally significant (significance calculated by the Monte Carlo
method [95% CI] ns). The lowest seroprevalence was observed
in Madrid (38.14%) (significance calculated by the Monte
Carlo method [CI 95%]; p < 0.001) (Table 1). The mean age
by region was as follows: 6.24 (SE = 0.183), 7.15
(SE = 0.250), 10.25 (SE = 0.320), 6.43 (SE = 0.161) and
8.26 (SE = 0.384) years for Andalusia, Castilla-La Mancha,
Castilla-León, Extremadura and Madrid, respectively.
In this study, it has been shown that T. equi, B. caballi and
mixed infection were detected across regions. Notably, the par-
asite detected most frequently was T. equi, ranging from 62.57
to 32.37% in Andalusia and Madrid, respectively (Table 1).
However, B. caballi prevalence was half as high, ranging from
31.16 to 12.20% in Castilla-León and Extremadura, respec-
tively (Table 1). The maximum of mixed infections was
16.38% in Castilla-León (Table 1). The regional seropreva-
lence for male and female horses is shown in Table 1 (see also
Table S2 for province details).
Approximately half of the tested Spanish Pure Breed
horses were seropositive (50.89%) consisting of 41.69% horses
T. equi seropositive and 16.32% seropositive for B. caballi.
Meanwhile, 9.90% of the tested horses were positive for both
parasites.
Figure 1. Map of equine piroplasmosis prevalence by region in Spain. The histogram within each province represents the positive horses
using percentages.
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Regarding the goodness of the LR-binary model
(v2 = 372.93; p < 0.0001 and B = 0.098 (SE = 0.038);
p < 0.006), age (p < 0.0001), breed (p < 0.004) and geograph-
ical location (p < 0.0001) were significant, explaining between
0.155 (Cox and Snell’s R2) and 0.207 (Nagelkerke’s R2) of the
dependent variable (seroprevalence), with 62.4% of the cases
correctly classified. This indicates that the model is acceptable.
Other risk factors, the coat colour and the gender, were not
significant and fall out of the model (Tables S3 and S4 for
T. equi and B. caballi, respectively, for details). The difference
between average age of the positive and the negative horses
(6.92 [95% CI: 6.61–7.22] subtracted from 8.19 [95% CI:
7.86–8.53]) by the T. equi IFAT test was 1.27 years. On the
basis of these results, non-overlap between the CIs of the aver-
age ages supported statistically significant differences in the
age of seropositivity, based on the IFAT test. Moreover, the
OR values between a specific age and the previous one were
slightly similar but significantly increased from three to
11 years of age. This was accompanied by a change of signif-
icance regarding the percentages in seroprevalence, reaching a
threshold of around 44–65% of positivity from eleven years of
age. Regarding the breed, OR values are significantly different
among non-native breeds such as Arabian horses, Thorough-
bred, Selle Français and crossbreeds, which always showed
OR values higher than those from the autochthonous
breeds like Spanish Pure Breed horses for T. equi. Focusing
on the geographical distribution, it was observed that there
was a higher risk of T. equi infection in Extremadura and
Castilla-León since the OR was significant.
A similar result was obtained for B. caballi, since neither
coat colour nor gender was risk factor for this parasitic
infection. The difference between the average age for seroneg-
ative and seropositive horses was 1.75 years (7.14 [95% CI:
6.90–7.39], that is the mean age of seronegative horses,
subtracted from 8.89 [95% CI: 8.31–9.57], that is the mean
age of seropositive through the IFAT test). This difference
was slightly higher than that for T. equi. The infection risk
increased until 12 years of age; from there, the seropositivity
settled around 20–45% and there were no significant
differences of seroprevalence above 12 years of age. However,
the OR between a specific age group and the previous one for
B. caballi was about three times higher than for T. equi, but
turnover (more frequent negativity change to more frequent
positivity) in favour of positivity from the nine-year threshold
occurs only for T. equi (Table S3). There was a significant
association between the breeds Arabian horses and Thorough-
bred, and seropositivity for B. caballi. The seropositivity rate in
Extremadura was significantly lower than in other regions.
IFAT vs. cELISA results
The concordance between the techniques was similar.
Of the 108 tested sera samples, both diagnostic methods
showed concordant results for T. equi in 91 sera (84.26%),
meanwhile for B. caballi the same results were observed in
89 samples (82.41%). Focusing on the anti-T. equi antibodies,
7 sera were positive by IFAT but were found negative by the
cELISA, and 10 serum samples were negative by IFAT but
positive by cELISA. Analysing the B. caballi results, it was
found that 16 horses had antibodies for that parasite by IFAT
but did not show reactivity in the cELISA, and three animals
were negative by IFAT but positive by cELISA (Table 2).
The concordance between the two serological methods for
T. equi using the j coefficient was 0.68. According to Landis
and Koch’s rating scale for the j index, there was substantial
agreement between the techniques. A fair agreement (Cohen’s
j = 0.22) was observed between the techniques for B. caballi.
Discussion
Equine piroplasmoses are diseases that affect a large number
of horses worldwide. Spain is an enzootic zone; therefore, infor-
mation about the prevalence of this infection in horse popula-
tions is essential to control the disease and to reduce the
economic losses generated. Different serological tests are
available for epidemiological studies (IFAT, cELISA) [56, 58].
Currently, both techniques are recommended by the World
Table 1. Prevalence of T. equi and B. caballi antibodies (by IFAT) in horses from different regions of Spain
Region Seroprevalence T. equi (% ± SE) B. caballi (% ± SE) Co-infection (% ± SE) Total (% ± SE)
Andalusia Males 241/560 (43.04 ± 0.021) 105/560 (18.75 ± 0.017) 77/560 (13.75 ± 0.014) 269 (48.04 ± 0.021)
Females 175/394 (44.42 ± 0.025) 107/394 (27.16 ± 0.022) 65/394 (16.50 ± 0.019) 217 (55.07 ± 0.025)
Overall 416 (43.61 ± 0.016) 212 (22.22 ± 0.013) 142 (14.88 ± 0.011) 486 (50.94 ± 0.016)
Castilla-La
Mancha
Males 125/207 (60.39 ± 0.034) 42/207 (20.29 ± 0.028) 34/207 (16.43 ± 0.026) 133 (64.25 ± 0.033)
Females 114/175 (65.14 ± 0.036) 37/175 (21.14 ± 0.031) 26/175 (14.86 ± 0.027) 125 (71.43 ± 0.034)
Overall 239 (62.57 ± 0.025) 79 (20.68 ± 0.021) 60 (15.71 ± 0.019) 258 (67.54 ± 0.024)
Castilla-León Males 165/424 (38.92 ± 0.024) 130/424 (30.66 ± 0.022) 62/424 (14.62 ± 0.017) 233 (54.95 ± 0.024)
Females 103/266 (38.72 ± 0.030) 85/266 (31.95 ± 0.029) 51/266 (19.17 ± 0.024) 137 (51.50 ± 0.031)
Overall 268 (38.84 ± 0.019) 215 (31.16 ± 0.018) 113 (16.38 ± 0.014) 370 (53.62 ± 0.019)
Extremadura Males 167/391 (42.71 ± 0.025) 61/391 (15.60 ± 0.018) 34/391 (8.70 ± 0.014) 194 (49.61 ± 0.025)
Females 190/371 (51.21 ± 0.026) 32/371 (8.63 ± 0.015) 23/371 (6.20 ± 0.013) 199 (53.64 ± 0.026)
Overall 357 (46.85 ± 0.018) 93 (12.20 ± 0.012) 57 (7.48 ± 0.010) 393 (51.67 ± 0.018)
Madrid Males 68/209 (32.54 ± 0.032) 24/209 (11.48 ± 0.022) 15/209 (7.18 ± 0.018) 77 (36.84 ± 0.033)
Females 33/103 (32.04 ± 0.046) 20/103 (19.42 ± 0.039) 11/103 (10.68 ± 0.031) 42 (40.78 ± 0.049)
Overall 101 (32.37 ± 0.027) 44 (14.10 ± 0.020) 26 (8.33 ± 0.016) 119 (38.14 ± 0.028)
(SE = Standard Error).
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Organisation for Animal Health for importation [73]. This study
mainly used the IFAT and 108 randomly selected samples were
analysed using both methods. Importantly, survey samples were
collected from a large area in Spain, which made it possible to
estimate the overall prevalence in a more realistic manner.
Several studies on the seroprevalence of EPs in Spain have been
published, although most of them were not as extensive as the
present survey. These diseases are widespread in Spain and
seroprevalence is high, as it has been reported by other authors
[21, 22, 35, 41, 43].
Recently, a survey carried out in all of Spain showed a
T. equi seroprevalence of 21.9%, a prevalence of 5% for
B. caballi and co-infection in 2.71% of the tested animals using
the cELISA [22]. In the Andalusia region, García-Bocanegra
et al. [35] reported a slightly higher seroprevalence for T. equi
(48.6% vs. 43.61% in the present survey), but the B. caballi
prevalence was 7.9% in the former, while in the present study
it was 22.22%. In 2005, Camacho et al. [21] in Galicia (north-
west Spain) estimated the seropositivity for B. caballi to be
28.3% in healthy horses using IFAT, which was similar to
our results. The difference could be explained by variations
in abiotic factors and tick fauna distribution. Furthermore,
the particular results for B. caballi may also be explained by
the use of different diagnostic techniques. Thus, in the present
study, it was revealed that the agreement between the cELISA
and the IFAT was poorer for B. caballi. This difference could
be due to the fact that IFAT slides were made with an auto-
chthonous strain, while the commercial cELISA kit used a
RAP-1 foreign antigen, leading to differences in the specificity
and the sensitivity of the techniques. As we did, Camacho et al.
[21] used the same IFAT technique, which led to a more accu-
rate comparison among regions using the data from both stud-
ies. The prevalence estimated in other countries with IFAT or
cELISA was different from the present survey. The EP preva-
lence was higher than in Spain in countries such as Colombia
(90%) [98], Brazil 78.8% and 65.7% for T. equi and
B. caballi, respectively, [44] or 97.5% for EP [100] and
Mongolia with 82.3% EP seroprevalence [16], or 78.8% for
T. equi and 65.7% for B. caballi, respectively [84]. However,
it was lower in countries such as the UAE (33.3%) [48], Sudan
(25.2%) [85], Portugal (17.9% and 11.1% for T. equi and
B. caballi, respectively) [80], Turkey (18.4–18.5%) [51, 90],
Jordan (14.6%) [2], Greece (11.6%) [56], Saudi Arabia
(10.4% and 7.5% for T. equi and B. caballi, respectively) [6],
Italy (8.5%) [40], Switzerland (7.3%) [92], the Netherlands
(4%) [19] and Korea (1.1%) [87]. In other studies, the T. equi
seroprevalence was higher than that described in Spain, but the
seropositivity for B. caballi was lower, this is the case for
France (from 58% to 80% for T. equi and from 1.2% to
12.9% for B. caballi) [33, 38] and Iran (48% and 2%) [1].
Meanwhile, a lower prevalence of T. equi was described in
Hungary (32%) [30], northern Italy (12.4%) [67] and the
Azores Islands (9.1%) [11]. The EP seroprevalence discrepan-
cies could be related to housing conditions, grazing and
activity of horses [38, 56, 100]. Also, the measures for control
of these diseases, the selected test for the diagnosis [2, 35, 56,
67], the climate and the tick fauna could be important. Thus,
temperature and/or humidity and/or precipitation could
increase or decrease tick populations [56, 94–96].
Using the IFAT, the T. equi seroprevalence was higher than
that of B. caballi. Different trends were observed by other
authors using different techniques (Table 3). T. equi was the
predominant parasite in 82.14% of the studies in respect to
B. caballi, but after excluding two studies [60, 81] due to
discrepancies between diagnostic methods regarding the
predominant haemoparasite.
Infected horses may remain lifelong carriers of T. equi,
whereas B. caballi is eliminated from the bloodstream
1–4 years post-infection, which could explain the seropreva-
lence difference for these parasites [12, 28, 85]. This fact could
explain why in horses older than nine years, the percentage of
infected animals exceeds that of uninfected animals in the case
of T. equi, which never occurs for B. caballi. Furthermore,
treatments do not completely eliminate T. equi from the
animals [18, 28]. The situation reported by other authors is
different since B. caballi is more prevalent than T. equi, which
has been related to the presence of the appropriate tick vectors
for the transmission of B. caballi [69].
Several authors [4, 12, 35, 38, 45, 49, 50, 56, 70, 74, 77,
79, 84, 90, 100] suggested that age was a risk factor, since
older animals could have been exposed to ticks for a longer
period than young animals. Nevertheless, other authors showed
the absence of an age-prevalence relationship [1, 3, 8, 10, 17,
23, 26, 36, 40, 46, 69, 75, 76, 80, 92, 94]. The present study
pointed out that less than 1/4 of the foals and yearlings were
seropositive for both parasites, with an increase in the percent-
age of infected horses until stabilisation at 11 and 14 years of
age for T. equi and B. caballi, respectively, as Cantú-Martínez
et al. reported [23]. Other studies have also reported that
T. equi antibodies were higher in older than in young animals
[8, 9, 27, 50, 51, 56]. In addition, Vieira et al. [100] indicate
that the seroprevalence of T. equi increased with age but in
contrast, the presence of antibodies to B. caballi decreased
in the oldest animals, which resembles the pattern described
in this study. There is evidence that animals infected with
T. equi may become lifelong carriers [18]. However, infection
with B. caballi may also persist in the subclinical state for
1–4 years only. This fact may partially explain our results,
whereby T. equi seroprevalence remained over 60% from
eleven years of age, but B. caballi seroprevalence did not
exceed the level of 44% in 16-year-old horses in Spain, where
these parasites cohabit.
It was found that Spanish breeds have a lower infection
prevalence than non-native breeds. Sevinc et al. [90] and
Table 2. Serological results by IFAT and cELISA for T. equi (A) and
B. caballi (B), respectively.
cELISA
Positive Negative Total
T. equi (A)
IFAT Positive 48 7 55
Negative 10 43 53
Total 58 50 108
B. caballi (B)
IFAT Positive 4 16 20
Negative 3 85 88
Total 7 101 108
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Table 3. T. equi and B. caballi prevalence by different diagnostic methods, including geographical distribution and predominant parasite.
Diagnostic
method
Continent Country Sample
size
Prevalence in %
(T. equi vs. B. caballi)
Predominant
parasite
References
CFT America Brazil 582 28.5 and 54.6 B. caballi > T. equi Kerber et al. 2009 [53]
Europe France 443 58 and 12.9 T. equi > B. caballi Guidi et al. 2015 [38]
ELISA Africa Egypt 88 14.8 and 0 T. equi > B. caballi Mahmoud et al. 2016 [62]
Sudan 158 63.5 and 4.4 T. equi > B. caballi Salim et al. 2008 [85]
America Brazil 47 81 and 90 B. caballi > T. equi Xuan et al. 2001 [104]
Brazil 582 26.6 and 69.6 B. caballi > T. equi Kerber et al. 2009 [53]
Brazil 198 78.3 and 69.2 T. equi > B. caballi Vieira et al. 2013 [100]
Costa Rica 130 88.5 and 69.2 T. equi > B. caballi Posada-Guzmán et al. 2015 [75]
Venezuela 360 50.3 and 70.5 B. caballi > T. equi Mujica et al. 2011 [69]
Venezuela 694 14 and 23.2 B. caballi > T. equi Rosales et al. 2013 [81]
Asia China 70 40 and 24.3 T. equi > B. caballi Xuan et al. 2002 [105]
China 111 34 and 32 T. equi > B. caballi Xu et al. 2003 [103]
China 1990 11.51 and 51.16 B. caballi > T. equi Wang et al. 2014 [101]
UAE 105 32.4 and 4.8 T. equi > B. caballi Jaffer et al. 2010 [48]
India 180 75 and 1.11 T. equi > B. caballi Sumbria et al. 2016 [96]
Japan 2019 2.2 and 5.4 B. caballi > T. equi Ikadai et al. 2002 [47]
Jordan 253 14.6 and 0 T. equi > B. caballi Abutarbush et al. 2012 [2]
Korea 184 1.1 and 0 T. equi > B. caballi Seo et al. 2011 [87]
Mongolia 254 72.8 and 40.1 T. equi > B. caballi Boldbaatar et al. 2005 [16]
Mongolia 250 51.6 and 19.6 B. caballi > T. equi Munkhjargal et al. 2013 [70]
Pakistan 430 41.2 and 21.6 T. equi > B. caballi Hussain et al. 2014 [46]
Thailand 240 5.42 and 2.5 T. equi > B. caballi Kamyingkird et al. 2014 [50]
Turkey 481 16.21 and 0.83 T. equi > B. caballi Sevinc et al. 2008 [90]
Turkey 220 56.8 and 0 T. equi > B. caballi Kurt and Yaman 2012 [57]
Europe Greece 524 9.2 and 1.1 T. equi > B. caballi Kouam et al. 2010 [56]
Italy 673 39.8 and 8.9 T. equi > B. caballi Bartolomé del Pino et al. 2016 [12]
Portugal 162 17.9 and 11.1 T. equi > B. caballi Ribeiro et al. 2013 [80]
Spain 380 48.6 and 7.9 T. equi > B. caballi García-Bocanegra et al. 2013 [35]
Spain 1067 21.9 and 5 T. equi > B. caballi Camino et al. 2016 [22]
IFAT Africa Egypt 88 23.9 and 17.0 T. equi > B. caballi Mahmoud et al. 2016 [62]
South Africa 92 97.83 and 52.17 T. equi > B. caballi Motloang et al. 2008 [68]
America Brazil 93 33.3 and 68.8 B. caballi > T. equi Asgarali et al. 2007 [8]
Brazil 487 91.0 and 83 T. equi > B. caballi Heim et al. 2007 [44]
Mexico 248 45.2 and 27.4 T. equi > B. caballi Cantú-Martínez et al. 2012 [23]
Asia Iran 100 48 and 2 T. equi > B. caballi Abedi et al. 2014 [1]
Saudi Arabia 241 10.4 and 7.5 T. equi > B. caballi Alanazi et al. 2012 [6]
Thailand 240 8.75 and 5 T. equi > B. caballi Kamyingkird et al. 2014 [50]
Turkey 110 64.5 and 4.5 T. equi > B. caballi Akkan et al. 2003 [5]
Turkey 84 23.8 and 38 B. caballi > T. equi Acici et al. 2008 [3]
Turkey 125 12.8 and 9.6 T. equi > B. caballi Karatepe et al. 2009 [51]
UAE 105 33.3 and 10.5 T. equi > B. caballi Jaffer et al. 2010 [48]
Europe Italy 412 12.4 and 17.9 B. caballi > T. equi Moretti et al. 2010 [67]
Italy 294 8.2 and 0.3 T. equi > B. caballi Grandi et al. 2011 [40]
Italy 300 41 and 26 T. equi > B. caballi Laus et al. 2013 [60]
Italy 1441 32.2 and 1.9 T. equi > B. caballi Sgorbini et al. 2015 [89]
Netherlands 300 1 and 3 B. caballi > T. equi Butler et al. 2012 [19]
Spain 60 40 and 28.3 T. equi > B. caballi Camacho et al. 2005 [21]
Spain – 52.5 and 21.3 T. equi > B. caballi Habela et al. 2005 [43]
Switzerland 689 4.4 and 1.5 T. equi > B. caballi Sigg et al. 2010 [92]
PCR Africa Egypt 88 36.4 and 19.3 T. equi > B. caballi Mahmoud et al. 2016 [62]
South Africa 92 5.43 and 0 T. equi > B. caballi Motloang et al. 2008 [68]
Sudan 131 25.2 and 0 T. equi > B. caballi Salim et al. 2008 [85]
Sudan 499 35.95 and 0 T. equi > B. caballi Salim et al. 2013 [86]
Tunisia 104 11.54 and 0.96 T. equi > B. caballi Ros-García et al. 2013 [82]
America Brazil 487 59.7 and 12.5 T. equi > B. caballi Heim et al. 2007 [44]
Costa Rica 130 46.2 and 20 T. equi > B. caballi Posada-Guzmán et al. 2015 [75]
Guatemala 74 52 and 48 T. equi > B. caballi Teglas et al. 2005 [97]
Venezuela 136 61.8 and 4.4 T. equi > B. caballi Rosales et al. 2013 [81]
Asia India 180 14.14 and 0 T. equi > B. caballi Sumbria et al. 2016 [96]
(continued on next page)
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Aharonson-Raz et al. [4] recognised that the seroprevalence in
Arabian horses was higher, as also found in the present study,
especially for B. caballi. Bartolomé del Pino et al. [12] indi-
cated that the prevalence in crossbred horses was significantly
higher than other (pure) breeds. Other surveys showed no asso-
ciation between infection prevalence and breed [2, 10, 36, 75].
Shkap et al. [91] considered that the differences in preva-
lence between male and female horses may be due to different
management practices for the two sexes. In the present study,
however, differences between male and female horses were
not observed.
In contrast to Aharonson-Raz et al. [4], no significant
association between coat colour and the results of the diagnos-
tic test was observed. Further studies are needed to understand
the origin of this difference.
Significantly higher seroprevalence was obtained only in
Extremadura and Castilla-León horses. There have also been
studies that demonstrated statistically significant differences
between counties or regions [2, 3, 8, 12, 16, 26, 29, 35, 51,
52, 56, 87, 91, 94, 96].
With respect to Cohen’s j analysis, the concordance
between the IFAT and the cELISA for T. equi was higher than
for B. caballi, showing a fair agreement for B. caballi.
The EMA-1 gene of the strains used to make the T. equi recom-
binant antigen in the cELISA and the strains from Spain were
probably similar. Consequently, for B. caballi, the different
results between this technique and cELISA may be related to
this fact. However, the RAP-1 gene of strains used to make
the recombinant antigen in the cELISA could be different from
the RAP-1 gene of Spanish strains. Recently, Montes et al. [66]
showed one Spanish B. caballi strain to be genetically different
from that described by Cacciò et al. [20] based on the b-tubulin
gene. Also, the existence of genetic differences between strains
within a country or among countries has been reported previ-
ously [14, 25, 71]. These authors showed that there was hetero-
geneity in the 18S rRNA gene both for T. equi and B. caballi
in Spain and South Africa. In support of our study and
focusing on the RAP-1 gene of B. caballi, Bhoora et al. [15],
Rapoport et al. [79] and Mahmoud et al. [62] indicated failure
to detect the B. caballi parasite. In accordance with Rapoport
et al. [79], there could be doubts as to the ability of the cELISA
to serve as a sole regulatory test for the international horse
trade. The IFAT used in the present survey was performed with
Spanish B. caballi strains, since it appears that they detect the
presence of haemoparasite antibodies more successfully than
the cELISA. Thus, Kuttler et al. [59] and Prochno et al. [76]
confirmed that, due to regional differences, the use of antigens
from autochthonous strains provides the best results.
Conclusions
The risk factors that seem to be associated with the
presence of equine piroplasmoses in Spain are age, breed
and geographical location. Meanwhile, coat colour and gender
were not significantly associated in these diseases. The sero-
prevalence in young animals is relatively low, but as horses
get older they become seropositive, especially concerning
T. equi. In addition, the comparison between IFAT and cELISA
revealed a possible underestimation of the presence of
B. caballi when using cELISA.
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